Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers

被引：44
作者：
Appiah-Kubi, Kwaku [1 ,3 ]
Wang, Ying [1 ]
Qian, Hai [1 ]
Wu, Min [1 ]
Yao, Xiaoyuan [2 ]
Wu, Yan [1 ]
Chen, Yongchang [1 ]
机构：
[1] Jiangsu Univ, Sch Med, Dept Physiol, Zhenjiang 212013, Jiangsu, Peoples R China
[2] Changchun Med Coll, Basic Med Dept, Changchun 130013, Jilin, Peoples R China
[3] Univ Dev Studies, Dept Appl Biol, Navrongo, Ghana
来源：
TUMOR BIOLOGY | 2016年 / 37卷 / 08期
基金：
中国国家自然科学基金; 中国博士后科学基金;
关键词：
PDGFR/PDGF system; Therapeutic targets; Prognostic marker; Treatment response biomarker; Small molecules; Immunotherapy; Gene therapy; RENAL-CELL CARCINOMA; RECEPTOR-ALPHA EXPRESSION; COPY NUMBER GAIN; PHASE-II TRIAL; IMATINIB MESYLATE; FACTOR PDGF; MONOCLONAL-ANTIBODY; RNA INTERFERENCE; POTENT INHIBITOR; PROSTATE-CANCER;
D O I：
10.1007/s13277-016-5069-z
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Progress in cancer biology has led to an increasing discovery of oncogenic alterations of the platelet-derived growth factor receptors (PDGFRs) in cancers. In addition, their overexpression in numerous cancers invariably makes PDGFRs and platelet-derived growth factors (PDGFs) prognostic and treatment markers in some cancers. The oncologic alterations of the PDGFR/PDGF system affect the extracellular, transmembrane and tyrosine kinase domains as well as the juxtamembrane segment of the receptor. The receptor is also involved in fusions with intracellular proteins and receptor tyrosine kinase. These discoveries undoubtedly make the system an attractive oncologic therapeutic target. This review covers elementary biology of PDGFR/PDGF system and its role as a prognostic and treatment marker in cancers. In addition, the multifarious therapeutic targets of PDGFR/PDGF system are discussed. Great potential exists in the role of PDGFR/PDGF system as a prognostic and treatment marker and for further exploration of its multifarious therapeutic targets in safe and efficacious management of cancer treatments.
引用
收藏
页码：10053 / 10066
页数：14
相关论文
共 138 条
[91]   Inhibition of Prostate Cancer Using RNA Interference-directed Knockdown of Platelet-derived Growth Factor Receptor [J].
Park, Yong Hyun ;
Seo, Su Yeon ;
Ha, Minju ;
Ku, Ja Hyeon ;
Kim, Hyeon Hoe ;
Kwak, Cheol .
UROLOGY, 2011, 77 (06) :1509.e9-1509.e15
[92]   Prognostic Significance of Stromal Platelet-Derived Growth Factor β-Receptor Expression in Human Breast Cancer [J].
Paulsson, Janna ;
Sjoblom, Tobias ;
Micke, Patrick ;
Ponten, Fredrik ;
Landberg, Goran ;
Heldin, Carl-Henrik ;
Bergh, Jonas ;
Brennan, Donal J. ;
Jirstrom, Karin ;
Ostman, Arne .
AMERICAN JOURNAL OF PATHOLOGY, 2009, 175 (01) :334-341
[93]   Identification of novel FLT3 kinase inhibitors [J].
Pauwels, Daphnie ;
Klaassen, Hugo ;
Lahortiga, Idoya ;
Kilonda, Amuri ;
Jacobs, Kris ;
Sweron, Bram ;
Corbau, Romuald ;
Chaltin, Patrick ;
Marchand, Arnaud ;
Cools, Jan .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 63 :713-721
[94]  
Pendergrast P Shannon, 2005, J Biomol Tech, V16, P224
[95]   RETRACTED: MicroRNA-34A inhibits the growth, invasion and metastasis of gastric cancer by targeting PDGFR and MET expression (Retracted article. See vol. 43, 2023) [J].
Peng, Yang ;
Guo, Jin-Jun ;
Liu, Yan-Min ;
Wu, Xiao-Ling .
BIOSCIENCE REPORTS, 2014, 34 :247-256
[96]  
Pietras K, 2002, CANCER RES, V62, P5476
[97]   Mutation in the platelet-derived growth factor receptor alpha inhibits adeno-associated virus type 5 transduction [J].
Pilz, Ingo H. ;
Di Pasquale, Giovanni ;
Rzadzinska, Agnieszka ;
Leppla, Stephen H. ;
Chiorini, John A. .
VIROLOGY, 2012, 428 (01) :58-63
[98]   Discovery of AZD2932, a new Quinazoline Ether Inhibitor with high affinity for VEGFR-2 and PDGFR tyrosine kinases [J].
Ple, Patrick A. ;
Jung, Frederic ;
Ashton, Sue ;
Hennequin, Laurent ;
Laine, Romuald ;
Morgentin, Remy ;
Pasquet, Georges ;
Taylor, Sian .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) :262-266
[99]   Experience with sorafenib in the treatment of advanced renal cell carcinoma [J].
Procopio, Giuseppe ;
Verzoni, Elena ;
Testa, Isabella ;
Nicolai, Nicola ;
Salvioni, Roberto ;
DeBraud, Filippo .
THERAPEUTIC ADVANCES IN UROLOGY, 2012, 4 (06) :303-313
[100]  
Qin Yong, 2008
567891011121314